A transforming growth factor-β receptor-interacting protein frequently mutated in human ovarian cancer

Ovarian carcinomas, particularly recurrent forms, are frequently resistant to transforming growth factor-beta (TGF-beta)-mediated growth inhibition. However, mutations in the TGF-beta receptor I and receptor II (TbetaR-I and TbetaR-II) genes have only been reported in a minority of ovarian carcinoma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2005-08, Vol.65 (15), p.6526-6533
Hauptverfasser: WEI DING, QIAN TANG, ESPINA, Virginia, LIOTTA, Lance A, MAUGER, David T, MULDER, Kathleen M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!